Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

2.51
Delayed Data
As of 4:00pm ET
 -0.27 / -9.71%
Today’s Change
1.82
Today|||52-Week Range
7.69
-31.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash22.2M26.9M8.1M27.0M
 
 
 
 
 
Short Term Investment Cash7.1M4.7M-18.8M18.9M
 
 
 
 
 
Cash & Short Term Investments43.0M46.4M42.6M31.8M
 
 
 
 
 
 
ReceivablesReceivables--0.000.000.00--
 
InventoriesInventories--0.000.000.00--
 
Current AssetsOther Current Assets1.2M558.0K643.0K1.2M
 
 
 
 
 
Current Assets44.2M47.0M43.2M32.9M
 
 
 
 
 
 
Total AssetsOther Assets0.000.000.001.4M
 
 
Total Assets44.2M47.0M43.2M34.3M
 
 
 
 
 
 
LiabilitiesAccounts Payable0.002.5M1.9M1.7M
 
 
 
 
Short Term Debt9.3M7.8M3.3M7.2M
 
 
 
 
 
Accrued Expenses6.2M4.7M3.1M2.3M
 
 
 
 
 
Other Current Liabilities16.3M7.1M3.7M2.3M
 
 
 
 
 
Other Liabilities27.9M19.0M10.9M12.7M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.0011.1M0.00
 
 
Other Liabilities0.000.00169.0K112.0K
 
 
 
Total Liabilities30.4M19.6M22.2M12.8M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.0016.5M18.8M21.0M
 
 
 
 
Common Equity13.8M10.9M2.2M578.0K
 
 
 
 
 
Total Shareholder Equity13.8M27.4M21.0M21.5M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding11.0M14.4M20.9M34.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.